Pharmaceutical Technology's In the Lab eNewsletter
The company doubled capacity for laboratory services at its facility in Itasca, IL.
Nelson Laboratories announced on April 19, 2018 that it has invested in expansions of operations and service capabilities at the its laboratory facility in Itasca, IL.
The 10,000-square-foot expansion houses upgrades that include renovated lab space and a biological indicator sterility suite to support ethylene oxide sterilization validations. The company has expanded its test offerings to include more than double the capacity for bioburden, radiation sterilization validations, bacterial endotoxin testing, and product sterility testing for medical devices and pharmaceutical products.
New testing capabilities include medical device particulate testing, healthcare reprocessing validations, sterilization for reuse validations, and genetic microbial identification testing. These capabilities will be fully operational beginning May 1, 2018.
According to the company, its Itasca laboratory facility is now International Organization for Standardization 17025-accredited and adheres to the same quality system as the company’s global headquarters in Salt Lake City, UT. Additionally, clients are now able to track their submitted studies and retrieve test reports via the company’s secure customer portal.
“Our customers will benefit from our enhanced quality system and expanded services, as well as the unparalleled expertise and customer service they have come to trust from Nelson Labs,” said John S. Bolinder, vice president of North American lab operations at Nelson Labs, in a company press release. “In addition, we are able to offer the leading sterilization services of our sister company, Sterigenics, at multiple facilities located within close proximity to our Itasca laboratory. This allows us to more fully serve the needs of our sterilization and laboratory customers throughout the Midwestern region of the United States.”
Source: Nelson Labs
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.